{"name":"Onconova Therapeutics","slug":"onconova","ticker":"ONTX","exchange":"NASDAQ","domain":"onconova.com","description":"Onconova Therapeutics is a biopharmaceutical company focused on developing innovative therapies for patients with cancer. The company's pipeline includes several clinical-stage candidates, including Rigosertib, which is being investigated for the treatment of acute myeloid leukemia (AML). Onconova has a strong presence in the oncology and hematology markets, with a focus on addressing unmet medical needs in these areas.","hq":"Newtown, PA","founded":0,"employees":"","ceo":"Steven M. Fruchtman","sector":"Oncology / Hematology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$35M","metrics":{"revenue":2500000,"revenueGrowth":0,"grossMargin":0,"rdSpend":11430000,"netIncome":-166523000,"cash":24962000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Rigosertib patent cliff ($0.0B at risk)","drug":"Rigosertib","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Onconova Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Onconova Therapeutics reported its financial results for the fourth quarter and full year 2023, highlighting a net loss of $13.6 million for the quarter and $54.4 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Onconova Therapeutics Announces Collaboration with University of Pennsylvania to Develop New Cancer Therapies","summary":"Onconova Therapeutics announced a collaboration with the University of Pennsylvania to develop new cancer therapies, including a potential treatment for AML.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-12-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFA4NWpiTkZoVUlFX1ZFNUNlVDhOcFZxZEZaTmtuUmE0UWtucUJGcUpPVUZUVFRiYXc4Z2NOQ3REMk1yX2E0U1lLRlhfUWhCVXNNZWUw?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"ONTX Stock Price, News & Analysis - Stock Titan","headline":"ONTX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5lRThVM1ZOcVFsenFkdU1CdWNsWUc3YjdpYlNiQWJVeHFMbk5HaXRaSVNGY0MzX0NiX3lsa0l5eERQV3ZGY0ZvYVBPdGZQV2hocWFIbWEyNEpyXzRUU0VZTFZBTHIwdWlxT0ZvQjRiMFNsdmZJci1LR3RxRnBGRzg?oc=5","date":"2024-04-10","type":"pipeline","source":"orrick.com","summary":"‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com","headline":"‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5DclJuM3E2b29OaHEtY3diazQydGJnV2thS1llaXRRalc2SXpWbmdnTnhzV2ZYUUlXSG9hNnBseXE1QTBVcUN1WERuRXUyNlhXY2E3RHFZZXdmTGZXN2R3WkZmQTdHc1U?oc=5","date":"2021-05-20","type":"pipeline","source":"Market Realist","summary":"Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist","headline":"Why Onconova Therapeutics (ONTX) Stock Is Up Sharply","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPN0R5NG5ET3R6RHJzbUljVGowOGRxNUcyZGNQS0pKUXZzMEpHM2czWWtVOXNYRWtxTmZCOEh1ekpGbjhHVFZBNGl2UDFUWjlQWThLSUNrNVZmUmdiSl92UGFabzNMNEdFZUx6TlZ5MFNiRmpKcGRtbHlmR2k3VVowZ2gtUQ?oc=5","date":"2021-05-14","type":"pipeline","source":"Yahoo Finance","summary":"7 Reddit Penny Stocks Promising to Cure Cancer - Yahoo Finance","headline":"7 Reddit Penny Stocks Promising to Cure Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNNmRLeWQ2UENacHFIZ3pYOTZZMkhtMGl6UTVkcGpNZllNX0ZxMEw2U3RzMFpWTXpoSk9UWlRhd2R0dmNtRVJvbmYwZHE4Tzc3MFBTLUVLSzdBRTBxTFFYbzNvamtNVDRUTjVNOEwxTkMteC1CUndMM21WY1B4a2FMSXo4RDJwX3NydTRKbA?oc=5","date":"2020-10-09","type":"trial","source":"Yahoo Finance","summary":"Jazz Pharma's Xywav Succeeds in Idiopathic Hypersomnia Study - Yahoo Finance","headline":"Jazz Pharma's Xywav Succeeds in Idiopathic Hypersomnia Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WbWlVSlJjQzRxejY3alFYWTB4cEJySW5DMnQyUlRack9tekJvS2pnZG9tczM3N25RUmp1UE9oSXh1V3JGdlBSU0RxVFZVYzRZWUloMDNITHpIU2RnYUI4?oc=5","date":"2019-12-10","type":"pipeline","source":"ChartMill","summary":"ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX) - ChartMill","headline":"ONTX Stock Price, Quote & Chart | ONCONOVA THERAPEUTICS INC (NASDAQ:ONTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPeVI0OVZVU2JaekFaZ0pHQlVVVllmLUdrWEEwcTdrdGtjNkViQ0Rib3dVdy13SVcxQXpTLVNBbUVuS2JkQjdRUTR2eWhuN00wLUdOWDE3SjEzdnhhN2lLMl96aUpCSFZQdEtYRkNtOTVwR0tNbXhPakhzTktERElnRlFIMW1mdS1pYnV2Um9ETQ?oc=5","date":"2019-11-26","type":"regulatory","source":"Yahoo Finance","summary":"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug - Yahoo Finance","headline":"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Ge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQbjZtT3BJR0FwVDJlbEZWOWJ2TXhNak5HZ1BtaDR4SDhoTkZjWHNfZnpwenh2SWNQSVJyQS1mN2ltcU5JTEhKWTdRZFN6Y09NNkhrdEwyTW9IcVVjeHQteVpJYm54SlpkNDBaQ0YxNUw3NUFMU1RoZVZNNVQ0SFFSWTMtTlMyOEIwSFRjbE5zck4xemRmeWdEaTk0bG9Md184eVk3eHdpbHMyVFhHMXlvZ1pzbE94YVc4VTlLLXhaMVoyUkJEOVV6eWtSSTZaQ080OGZCU00xU0tfZUZHdGNBZUdOV2Z1QkZLNkVRZ1FKTk1KLW5MZmJoRGlDdnlGd3I3ZDRkaWVLX2JmTThfUEVyVldZSnR1Y2MzY2QyRTBmQmVleW1feEVQd1VIUUZkUFZYSmlHLXRfWXVMSGJmelo1SjFPOU9OdHBQalE?oc=5","date":"2018-03-05","type":"deal","source":"GlobeNewswire","summary":"Onconova Therapeutics Announces License Agreement with Pint - GlobeNewswire","headline":"Onconova Therapeutics Announces License Agreement with Pint","sentiment":"neutral"}],"patents":[{"drugName":"Rigosertib","drugSlug":"rigosertib","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Bayer","Novartis","Celgene"],"therapeuticFocus":["Oncology","Hematology"],"financials":{"source":"sec_edgar+yahoo","revenue":226000,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":226000,"period":"2024-12-31"},{"value":226000,"period":"2023-12-31"},{"value":226000,"period":"2023-12-31"},{"value":226000,"period":"2022-12-31"},{"value":226000,"period":"2022-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":11430000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-166523000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":24962000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}